Since its FDA approval in 2002, Atomoxetine (brand name Strattera) has become a second or third line option (after stimulants and sometimes after central alpha agonists) for ADHD in both children and adults. Does it work? Listen and find out!
https://www.thecarlatreport.com/blog/is-watching-13-reasons-why-bad-for-teens-2/
Join Josh Feder, MD, and Mara Goverman, LICW, for a special episode focused on child psychiatry, suicidality, and the popular Netflix series 13 Reasons Why. The show stirred controversy when it portrayed the bullying and suicide of a teenager. Although the program increased awareness of these issues, some clinicians argued that it glamorized the suicide. Netflix has since cut the suicide scene from its streaming service. In July, JAMA published a study of CDC data showing that suicide rates went up 13.3% in the 10 to 19 age group after the suicide episode was originally released in 2017. Evidence suggests portrayals of suicide like this are contagious, but what do clinicians and parents do about it in an age of private streaming media?
Publication Date: 8/12/19
Runtime: 9 minutes, 5 seconds
Articles Referenced:
Is Watching ‘13 Reasons Why’ Bad for Teens?, The Carlat Child Psychiatry Report, March 2019
Voelker R. Mounting Evidence and Netflix’s Decision to Pull a Controversial Suicide Scene. JAMA. Published online July 24, 2019. doi:10.1001/jama.2019.9492
Audio clips of Edwin Schneidman, MD, provided by Regenerate Films, which is part of the nonprofit Regenerate. They were made during Dr. Schneidman’s consultation on the Netflix film “My Suicide.”
You Might Also Enjoy...
Since its FDA approval in 2002, Atomoxetine (brand name Strattera) has become a second or third line option (after stimulants and sometimes after central alpha agonists) for ADHD in both children and adults. Does it work? Listen and find out!
ADHD is one of the most treatable conditions in psychiatry if patients adhere to medication regimens. So, why are parents so resistant to stimulant medications and how can we approach these misconceptions?
Each year in the US, there are about 1.04 million divorces, affecting about 800,000 children. How can we navigate the complexities of treating a child with divorce?
Do antipsychotics have neurotoxic effects in youth? In this episode, we’ll be banging the drum of caution about antipsychotic use in children and adolescents.
With a growing body of evidence supporting its clinical efficacy and cost-effectiveness relative to traditional ABA approaches, the developmental model is being used with increasing prevalence across the US.
Prescribing Psychotropics bridges the gap between the complexities of drug pharmacokinetics and everyday clinical practice, providing clinicians more insight into how psychiatric drugs behave (or misbehave!) once their patients take them.